PharMerica Acquires CareMed Specialty Pharmacy
16 Mars 2017 - 9:15PM
Business Wire
PharMerica Corporation (NYSE:PMC), a diversified national
provider of institutional and specialty pharmacy services,
announced today that it has completed the acquisition of CareMed
Specialty Pharmacy (“CareMed”). Terms of the transaction were not
disclosed.
CareMed, based in New Hyde Park, NY, and licensed in all 50
states, provides comprehensive specialty pharmacy services
nationally and is known industry-wide for its commitment to
excellence and customer service.
Greg Weishar, PharMerica Corporation’s Chief Executive Officer,
stated, “The CareMed acquisition is in line with the Company’s
diversified business strategy and further bolsters our position in
the rapidly growing specialty pharmacy market. We look forward to
working with the talented CareMed management team to deliver value
to all PharMerica stakeholders.”
“We are pleased to have reached this agreement and believe we
have found an ideal partner in PharMerica,” said Dr. Moby Kazmi,
Chief Executive Officer of CareMed. “Like CareMed, PharMerica
adheres to the highest standards of care and service. We look
forward to realizing the significant benefits this transaction will
bring to our customers and employees.”
About PharMerica
PharMerica Corporation is a leading provider of pharmacy
services. PharMerica serves the long-term care, hospital pharmacy
management services, specialty home infusion and oncology pharmacy
markets. PharMerica operates 98 institutional pharmacies, 19
specialty home infusion pharmacies and 4 specialty oncology
pharmacies in 45 states. PharMerica’s customers are institutional
healthcare providers, such as skilled nursing facilities, assisted
living facilities, hospitals, individuals receiving in-home care
and patients with cancer.
Forward-looking Statements
This press release contains “forward-looking statements” within
the meaning of Section 27A of the Securities Act of 1933, as
amended, and Section 21E of the Securities Exchange Act of 1934, as
amended, which reflect the Company’s current estimates,
expectations and projections about its future results, performance,
prospects and opportunities. Forward-looking statements include,
among other matters, the Company’s expectations with respect to the
acquisition of CareMed, the Company’s ability to realize
significant benefits that the CareMed acquisition could bring to
its patients, providers and employees, and CareMed’s future
performance. Forward-looking statements include statements that are
not historical facts and can be identified by forward-looking words
such as “anticipate,” “believe,” “could,” “estimate,” “expect,”
“intend,” “plan,” “may,” “should,” “will,” “would,” “project” and
similar expressions. These forward-looking statements are based
upon information currently available to us and are subject to a
number of risks, uncertainties and other factors that could cause
the Company’s actual results, performance, prospects or
opportunities to differ materially from those expressed in, or
implied by, these forward-looking statements. Important factors
that could cause the Company’s actual results to differ materially
from the results referred to in the forward-looking statements we
make in this press release include our ability to effectively and
successfully execute, manage and integrate the CareMed acquisition,
the Company’s ability to continue to execute its strategic
initiatives, and those included in the Risk Factors section set
forth in the Company’s Annual Report on Form 10-K filed with the
SEC and in other reports, including Quarterly Reports on Form 10-Q
filed with the SEC by the Company.
You are cautioned not to place undue reliance on any
forward-looking statements, all of which speak only as of the date
of this press release. Except as required by law, we undertake no
obligation to publicly update or release any revisions to these
forward-looking statements to reflect any events or circumstances
after the date of this press release or to reflect the occurrence
of unanticipated events. All subsequent written and oral
forward-looking statements attributable to us or any person acting
on the Company’s behalf are expressly qualified in their entirety
by the cautionary statements contained or referred to in this press
release and in the Risk Factors section set forth in the Company’s
Annual Report on Form 10-K filed with the SEC and in other reports
filed with the SEC by the Company.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20170316005958/en/
PharMerica CorporationRobert Dries, 502-627-7950Executive Vice
President and Chief Financial Officer
Pharmerica Corp. (delisted) (NYSE:PMC)
Graphique Historique de l'Action
De Mai 2024 à Juin 2024
Pharmerica Corp. (delisted) (NYSE:PMC)
Graphique Historique de l'Action
De Juin 2023 à Juin 2024